Findings on Respiratory Syncytial Viruses Reported by Investigators at AstraZeneca [Molecular and Phenotypic Characteristics of Respiratory Syncytial Virus Isolates Recovered From Medically Vulnerable Children: an Exploratory Analysis of a Phase...].

MLA

“Findings on Respiratory Syncytial Viruses Reported by Investigators at AstraZeneca [Molecular and Phenotypic Characteristics of Respiratory Syncytial Virus Isolates Recovered From Medically Vulnerable Children: An Exploratory Analysis of a Phase...].” Clinical Trials Week, Oct. 2024, p. 991. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=180469722&authtype=sso&custid=ns315887.

APA

Findings on Respiratory Syncytial Viruses Reported by Investigators at AstraZeneca [Molecular and Phenotypic Characteristics of Respiratory Syncytial Virus Isolates Recovered From Medically Vulnerable Children: an Exploratory Analysis of a Phase...]. (2024). Clinical Trials Week, 991.

Chicago

“Findings on Respiratory Syncytial Viruses Reported by Investigators at AstraZeneca [Molecular and Phenotypic Characteristics of Respiratory Syncytial Virus Isolates Recovered From Medically Vulnerable Children: An Exploratory Analysis of a Phase...].” 2024. Clinical Trials Week, October, 991. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=180469722&authtype=sso&custid=ns315887.